Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.85852 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Emma Guttman-Yassky und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Guttman-Yassky, E., Katoh, N., J Cork, M., Jagdeo, J., F Alexis, A., Chen, Z., A Levit, N., & B Rossi, A. (2025). Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.85852
Vancouver
Guttman-Yassky E, Katoh N, J Cork M, Jagdeo J, F Alexis A, Chen Z, et al. Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.85852
BibTeX
@article{GuttmanYassky2025,
author = {Guttman-Yassky, Emma and Katoh, Norito and J Cork, Michael and Jagdeo, Jared and F Alexis, Andrew and Chen, Zhen and A Levit, Noah and B Rossi, Ana},
title = {Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.85852}
}
EUVIMED